Cite
Shahab O, Biswas R, Paik J, et al. Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality. Hepatol Commun. 2018;2(10):1227-1234doi: 10.1002/hep4.1241.
Shahab, O., Biswas, R., Paik, J., Bush, H., Golabi, P., & Younossi, Z. M. (2018). Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality. Hepatology communications, 2(10), 1227-1234. https://doi.org/10.1002/hep4.1241
Shahab, Omer, et al. "Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality." Hepatology communications vol. 2,10 (2018): 1227-1234. doi: https://doi.org/10.1002/hep4.1241
Shahab O, Biswas R, Paik J, Bush H, Golabi P, Younossi ZM. Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality. Hepatol Commun. 2018 Sep 24;2(10):1227-1234. doi: 10.1002/hep4.1241. eCollection 2018 Oct. PMID: 30288477; PMCID: PMC6167074.
Copy
Download .nbib